Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Psychotropic medication expenditures for community-dwelling elderly persons.

Aparasu R, Mort J, Brandt H.

Psychiatr Serv. 2003 May;54(5):739-42.

PMID:
12719508
2.

Expenditures for psychotropic medications in the United States in 1985.

Zorc JJ, Larson DB, Lyons JS, Beardsley RS.

Am J Psychiatry. 1991 May;148(5):644-7.

PMID:
2018168
3.

Psychotropic prescription use by community-dwelling elderly in the United States.

Aparasu RR, Mort JR, Brandt H.

J Am Geriatr Soc. 2003 May;51(5):671-7.

PMID:
12752843
4.

Medicaid expenditures on psychotropic medications for children in the child welfare system.

Raghavan R, Brown DS, Thompson H, Ettner SL, Clements LM, Key W.

J Child Adolesc Psychopharmacol. 2012 Jun;22(3):182-9. doi: 10.1089/cap.2011.0135. Epub 2012 Apr 26.

5.
6.
7.

Trends in psychotropic medication costs for children and adolescents, 1997-2000.

Martin A, Leslie D.

Arch Pediatr Adolesc Med. 2003 Oct;157(10):997-1004.

PMID:
14557161
8.

Increases in Medicare prescription drug plan costs attributable to psychotropic medications.

Zivin K, McCammon RJ, Davis MM, Halasyamani LK, Kales HC.

Am J Geriatr Psychiatry. 2008 Aug;16(8):674-85. doi: 10.1097/JGP.0b013e3181794591.

PMID:
18669946
9.

Economic costs of diabetes in the US in 2002.

Hogan P, Dall T, Nikolov P; American Diabetes Association.

Diabetes Care. 2003 Mar;26(3):917-32.

PMID:
12610059
10.

Psychotropic prescribing for the elderly in office-based practice.

Aparasu RR, Mort JR, Sitzman S.

Clin Ther. 1998 May-Jun;20(3):603-16.

PMID:
9663374
11.

Lessons learned from trends in psychotropic drug expenditures in a canadian province.

Dewa CS, Goering P.

Psychiatr Serv. 2001 Sep;52(9):1245-7.

PMID:
11533401
12.

Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users.

Ong MK, Xu H, Zhang L, Azocar F, Ettner SL.

J Am Geriatr Soc. 2012 Jul;60(7):1292-7. doi: 10.1111/j.1532-5415.2012.04031.x. Epub 2012 Jun 21.

13.
14.

Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders.

Ong MK, Zhang L, Xu H, Azocar F, Ettner SL.

Psychiatr Serv. 2012 Jul;63(7):637-42. doi: 10.1176/appi.ps.201100331.

15.

Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.

LaVange LM, Silverman HA.

Natl Med Care Util Expend Surv B. 1987 Apr;(12):1-43.

PMID:
10313516
16.
17.

Medicaid expenditures on psychotropic medications for maltreated children: a study of 36 States.

Raghavan R, Brown DS, Allaire BT, Garfield LD, Ross RE.

Psychiatr Serv. 2014 Dec 1;65(12):1445-51. doi: 10.1176/appi.ps.201400028. Epub 2014 Nov 17.

18.

Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice.

Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil M, Burke LB.

J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):557-65. Review.

PMID:
10230187
19.

National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009.

Wu CH, Wang CC, Katz AJ, Farley J.

J Anxiety Disord. 2013 Mar;27(2):163-70. doi: 10.1016/j.janxdis.2012.11.004. Epub 2013 Jan 7.

PMID:
23428605
20.

Racial/ethnic differences in Medicaid expenditures on psychotropic medications among maltreated children.

Raghavan R, Brown DS, Allaire BT, Garfield LD, Ross RE, Snowden LR.

Child Abuse Negl. 2014 Jun;38(6):1002-10. doi: 10.1016/j.chiabu.2014.02.013. Epub 2014 Mar 16.

Items per page

Supplemental Content

Write to the Help Desk